Key takeaways:

Metabolic surgery showed several long-term benefits, like a lower risk for death, over GLP-1s.

Surgery should not be a “last resort” but instead a part of shared decision-making, a researcher told Healio.

Perspective from Wudeneh Mulugeta, MD, MPH, FACP

People with obesity and diabetes who undergo bariatric surgery face a significantly lower risk for several adverse health outcomes vs. those treated with GLP-1s, new data show.

“Surgery should not be reserved as a last resort; it should be part of early, shared decision-making for patients with type 2 diabetes and obesity,” Ali Aminian, MD, director of Cleveland Clinic’s Bariatric and Metabolic Institute, told Healio. “Evidence shows that surgery provides added, durable benefits beyond medications alone.”

Metabolic s

See Full Page